Alisia Sim

Alisia Sim currently serves as a Board Member at DIESSE Diagnostica Senese S.p.A. and as an Associate at ARCHIMED, where Alisia has held multiple roles including Senior Analyst and Analyst since April 2021. Alisia is also a Board Observer at Cube Biotech GmbH and previously served in the same capacity at PlasmidFactory GmbH & Co. KG. Prior experience includes working as an Associate and Business Analyst at PharmaVentures and conducting market research and due diligence as a Business Analyst at MedCap Funds. Alisia completed a PhD in Chemistry at The University of Edinburgh after obtaining an MChem in Chemistry for Drug Discovery from the University of Bath. Educational background includes a European Baccalaureate from the European School Culham.